A phase 2 multicenter, randomized, placebo- and active-comparator-controlled, dose-ranging trial to evaluate guselkumab for the treatment of patients with moderate to severe plaque-type psoriasis (X-PLORE)

• Book ID: 122268244
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 52 KB
• Volume: 70
• Category: Article
• ISSN: 1097-6787
• DOI: 10.1016/j.jaad.2014.01.675